BioCardia, Inc.
BCDA
$1.14
$0.043.64%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.98M | -1.48M | -2.05M | -2.71M | -2.30M |
| Total Depreciation and Amortization | 3.00K | 4.00K | 5.00K | 12.00K | 15.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 267.00K | 180.00K | 197.00K | 267.00K | 390.00K |
| Change in Net Operating Assets | -783.00K | -373.00K | 198.00K | 815.00K | -542.00K |
| Cash from Operations | -2.50M | -1.67M | -1.65M | -1.62M | -2.43M |
| Capital Expenditure | -6.00K | 0.00 | -1.00K | -- | -1.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -6.00K | 0.00 | -1.00K | -- | -1.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.00K | 6.78M | 1.70M | 212.00K | 39.00K |
| Repurchase of Common Stock | -197.00K | -- | -- | -- | -140.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -96.00K | -804.00K | -14.00K | -16.00K | -24.00K |
| Cash from Financing | -288.00K | 5.98M | 1.68M | 196.00K | -125.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.79M | 4.31M | 31.00K | -1.42M | -2.56M |